Literature DB >> 19002982

Survival of 3T3 cells expressing or co-expressing bFGF and/or IGF-I and/or IGF-II in low serum and serum free media.

D Li1, S Hettle, J McLean, C Macdonald.   

Abstract

The aim of this study was to improve the survival ofNIH3T3 cells in low serum or serum-free media by theendogenous expression of recombinant bFGF (basicfibroblast growth factor) and/or IGF (insulin-likegrowth factor) -I and II. Expression was detected byWestern blotting, and the growth characteristics ofdifferent transfected cell lines investigated in bothserum-free and low serum conditions and also in softagar. Morphological changes and the growth rate werecompared with growth in normal serum-containingmedium. The experimental data suggested that theexpression of either bFGF alone, or the co-expressionof bFGF and either IGF-I or II could improve thesurvival of NIH3T3 cells in low serum or serum-freemedia. The use of such lines could decrease the use ofserum in cell culture and thus both reduce the costsinvolved in this technique and simplify thedown-stream purification procedure in protein harvest.Hence, such lines may be of value in both experimentaland industrial applications.

Entities:  

Year:  2000        PMID: 19002982      PMCID: PMC3449889          DOI: 10.1023/A:1008151302358

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  16 in total

Review 1.  Serum-free cell culture.

Authors:  U Bjare
Journal:  Pharmacol Ther       Date:  1992       Impact factor: 12.310

2.  Effects of IGF-I on the synthesis and processing of glycosaminoglycan in cultured chick chondrocytes.

Authors:  S F Kemp; G L Kearns; W G Smith; M J Elders
Journal:  Acta Endocrinol (Copenh)       Date:  1988-10

3.  Regulation of human melanocyte growth, dendricity, and melanization by keratinocyte derived factors.

Authors:  P R Gordon; C P Mansur; B A Gilchrest
Journal:  J Invest Dermatol       Date:  1989-04       Impact factor: 8.551

4.  Insulin-like growth factor II blocks apoptosis of N-myc2-expressing woodchuck liver epithelial cells.

Authors:  D Yang; R Faris; D Hixson; S Affigne; C E Rogler
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

5.  Insulin-like growth factor I receptor prevents apoptosis and enhances neuroblastoma tumorigenesis.

Authors:  J R Singleton; A E Randolph; E L Feldman
Journal:  Cancer Res       Date:  1996-10-01       Impact factor: 12.701

6.  FGF and EGF are mitogens for immortalized neural progenitors.

Authors:  D L Kitchens; E Y Snyder; D I Gottlieb
Journal:  J Neurobiol       Date:  1994-07

7.  Human fetal and adult chondrocytes. Effect of insulinlike growth factors I and II, insulin, and growth hormone on clonal growth.

Authors:  U Vetter; J Zapf; W Heit; G Helbing; E Heinze; E R Froesch; W M Teller
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

8.  An immunohistochemical and in situ hybridization study of insulin-like growth factor I within fetal neuron cell cultures.

Authors:  R Schechter; J Whitmire; D Beju; K W Jackson; R Harlow; J R Gavin
Journal:  Brain Res       Date:  1995-01-23       Impact factor: 3.252

9.  Insulin-like growth factor-II overexpression in MCF-7 cells induces phenotypic changes associated with malignant progression.

Authors:  K J Cullen; M E Lippman; D Chow; S Hill; N Rosen; J A Zwiebel
Journal:  Mol Endocrinol       Date:  1992-01

10.  Basic fibroblast growth factor stimulates the sustained proliferation of mouse epidermal melanoblasts in a serum-free medium in the presence of dibutyryl cyclic AMP and keratinocytes.

Authors:  T Hirobe
Journal:  Development       Date:  1992-02       Impact factor: 6.868

View more
  1 in total

1.  Effects of clonal variation on growth, metabolism, and productivity in response to trophic factor stimulation: a study of Chinese hamster ovary cells producing a recombinant monoclonal antibody.

Authors:  Hussain Dahodwala; Mark Nowey; Tatyana Mitina; Susan T Sharfstein
Journal:  Cytotechnology       Date:  2011-08-06       Impact factor: 2.058

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.